Re: sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis.
O'Connor
Alec B
AB
D000928:Antidepressive Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life
D000928:Antidepressive Agents